Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nervgen Pharma

Clinical trials sponsored by Nervgen Pharma, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a daily injection restore hand function after spinal cord injury? Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Completed 1

Can a daily injection restore hand function after spinal cord injury?

Disease control Not yet recruiting

This trial tests whether NVG-291, an investigational peptide, can improve hand function and daily activities in adults with chronic cervical spinal cord injury. Participants receive either NVG-291 or a placebo by daily injection under the skin for 12 weeks. Researchers measure ch…

Phase 3 • Sponsor: NervGen Pharma • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC